Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early botulinum toxin A added to arm-hand rehabilitation for post-stroke upper-limb spasticity
NL-OMON28462Active, not recruiting
- Sponsor
- Adelante Therapeutics
- Start
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in Muscle spasm and stroke, sponsored by Adelante Therapeutics. Primary endpoint: Action Research Arm Test. Started Oct 2016; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
Muscle spasmstroke
Beyond the preview
Go deeper on NL-OMON28462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28462.